Return Home
HealthSearch
Health Guide

Canavan disease

Definition

Canavan disease is a condition that affects how the body breaks down and uses aspartic acid.

Alternative Names

Spongy degeneration of the brain; Aspartoacylase deficiency; Canavan - van Bogaert disease

Causes

Canavan disease is passed down (inherited) through families. It is more common among the Ashkenazi Jewish population than in the general population.

The lack of the enzyme aspartoacylase leads to a buildup of material called N-acetylaspartic acid in the brain. This causes the white matter of the brain to break down.

There are two forms of the disease:

Symptoms

Symptoms often begin in the first year of life. Parents tend to notice it when their child is not reaching certain developmental milestones, including head control.

Symptoms include:

Exams and Tests

A physical exam may show:

Tests for this condition include:

Treatment

There is no specific treatment available. Supportive care is very important to ease the symptoms of the disease. Lithium and gene therapy are being studied.

Support Groups

More information and support for people with Canavan condition and their families can be found at:

Outlook (Prognosis)

With Canavan disease, the central nervous system breaks down. People are likely to become disabled.

Those with the neonatal form often do not live beyond childhood. Some children may live into their teens. Those with the juvenile form often live a normal lifespan.

Possible Complications

This disorder may cause severe disabilities such as:

When to Contact a Medical Professional

Contact your health care provider if your child has any symptoms of Canavan disease.

Prevention

Genetic counseling is recommended for people who want to have children and have a family history of Canavan disease. Counseling should be considered if both parents are of Ashkenazi Jewish descent. For this group, DNA testing can almost always tell if the parents are carriers.

A diagnosis may be made before the baby is born (prenatal diagnosis) by testing the amniotic fluid, the fluid that surrounds the womb.

References

Dugoff L, Wapner RJ. Prenatal diagnosis of congenital disorders. In: Lockwood CJ, Copel JA, Dugoff L, et al, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia, PA: Elsevier; 2023:chap 30.

Elitt CM, Volpe JJ. Degenerative disorders of the newborn. In: Volpe JJ, ed. Volpe's Neurology of the Newborn. 7th ed. Philadelphia, PA: Elsevier; 2025:chap 33.

Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Defects in metabolism of amino acids: N-acetylaspartic acid (Canavan disease). In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 105.